Around the world, millions of people are at an increased risk of illness or death from taking poor-quality medicines used to prevent or treat devastating illnesses. With funding from partners like the United States Agency for International Development (USAID), USP strengthens medicines quality assurance systems, increases the supply of quality-assured medicines, and develops capacity to detect and remove poor-quality medicines from the market. By sharing scientific expertise and providing technical support and leadership, we help local regulators improve and sustain local health systems, and enable manufacturers to supply quality-assured essential medicines for years to come. Through these efforts, we’re able to help prevent and treat diseases like HIV/AIDS, tuberculosis, malaria, and neglected tropical diseases, and improve maternal, newborn and child health.
Poor-quality medicines and approaches
to achieving quality-assured medicines
in low- and middle-income countries
A four-part series by Devex explores
these global health challenges and
highlights the work of the Promoting
the Quality of Medicines (PQM) program,
funded by USAID and implemented by USP.
Protecting People and
Promoting Public Health
Working with national medicines
regulatory authorities to develop capacity
in medicines evaluation, inspection, and
Bringing Low-Cost, Essential
Medicines to Markets and Patients
Building manufacturing capacity is helping to
prevent shortages in quality-assured medicines
needed to treat TB, malaria, and HIV/AIDS.
Sharing and Partnerships
Information sharing and partnerships
are leading to sustainable
health systems strengthening.